Syncom Formulation (India) (NSE:SYNCOMF) Market Cap : ₹12,267 Mil (As of May. 12, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Syncom Formulation (India)'s share price for the quarter that ended in Dec. 2023 was ₹15.05. Syncom Formulation (India)'s Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 940 Mil. Therefore, Syncom Formulation (India)'s market cap for the quarter that ended in Dec. 2023 was ₹14,147 Mil.

Syncom Formulation (India)'s quarterly market cap increased from Jun. 2023 (₹7,097 Mil) to Sep. 2023 (₹7,896 Mil) and increased from Sep. 2023 (₹7,896 Mil) to Dec. 2023 (₹14,147 Mil).

Syncom Formulation (India)'s annual market cap stayed the same from Mar. 2021 (₹0 Mil) to Mar. 2022 (₹0 Mil) but then increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹5,546 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Syncom Formulation (India)'s Enterprise Value for Today is ₹12,454 Mil.

Syncom Formulation (India) Market Cap Historical Data

The historical data trend for Syncom Formulation (India)'s Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Market Cap Chart

Syncom Formulation (India) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Market Cap

Get a 7-Day Free Trial

5,546.00

Syncom Formulation (India) Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															8,319.00	5,546.00	7,097.00	7,896.00	14,147.00

Competitive Comparison of Syncom Formulation (India)'s Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syncom Formulation (India)'s Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Market Cap distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Market Cap falls into.

Syncom Formulation (India) Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Syncom Formulation (India)'s Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )	=	Share Price (A: Mar. 2023 )	*	Shares Outstanding (EOP) (A: Mar. 2023 )
	=	₹5.9	*	940
	=	₹5,546

Syncom Formulation (India)'s Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	₹15.05	*	940
	=	₹14,147

Syncom Formulation (India) (NSE:SYNCOMF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Syncom Formulation (India) Market Cap Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » Market Cap

Traded in Other Exchanges

524470:India

Address

207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018

Website

https://www.sfil.in

Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines